O	0	8	Emulsion
O	9	11	of
B-intervention	12	17	Olive
I-intervention	18	21	Oil
I-intervention	22	25	and
I-intervention	26	33	Calcium
I-intervention	34	43	Hydroxide
O	44	47	for
O	48	51	the
O	52	62	Prevention
O	63	65	of
B-condition	66	75	Radiation
I-condition	76	86	Dermatitis
O	87	89	in
O	90	107	Hypofractionation
O	108	112	Post
O	112	113	-
O	113	123	Mastectomy
O	124	136	Radiotherapy
O	136	137	:
O	138	139	A
O	140	150	Randomized
O	151	161	Controlled
O	162	167	Trial
O	167	168	.

O	169	173	Most
O	174	176	of
O	177	180	the
O	181	189	patients
O	190	193	who
O	194	198	have
O	199	203	been
O	204	211	treated
O	212	214	by
O	215	219	post
O	219	220	-
O	220	230	mastectomy
O	231	243	radiotherapy
O	244	245	(
O	245	249	PMRT
O	249	250	)
O	251	261	experience
O	262	266	skin
O	267	275	toxicity
O	275	276	.

O	277	282	There
O	283	287	have
O	288	292	been
O	293	296	few
O	297	304	studies
O	305	307	on
O	308	313	acute
O	314	323	radiation
O	324	334	dermatitis
O	335	337	in
B-eligibility	338	344	breast
I-eligibility	345	351	cancer
I-eligibility	352	360	patients
I-eligibility	361	364	who
I-eligibility	365	373	received
I-eligibility	374	391	hypofractionation
I-eligibility	392	396	PMRT
O	396	397	.

B-total-participants	398	400	62
O	401	409	patients
O	410	414	were
O	415	425	randomized
O	426	428	to
O	429	436	receive
O	437	438	a
B-control	439	446	general
I-control	447	451	skin
I-control	452	456	care
I-control	457	464	regimen
O	465	469	with
O	470	472	or
O	473	480	without
O	481	484	the
O	485	493	addition
O	494	496	of
O	497	499	an
O	500	508	emulsion
O	509	511	of
O	512	517	olive
O	518	521	oil
O	522	525	and
O	526	533	calcium
O	534	543	hydroxide
O	544	549	twice
O	550	551	a
O	552	555	day
O	555	556	,
O	557	561	from
O	562	565	the
O	566	576	initiation
O	577	579	of
O	580	584	PMRT
O	585	587	to
O	588	589	2
O	590	595	weeks
O	596	601	after
O	602	614	radiotherapy
O	614	615	.

O	616	623	Adverse
O	624	628	skin
O	629	638	reactions
O	639	642	and
O	643	646	the
O	647	654	Skindex
O	654	655	-
O	655	657	16
O	658	663	score
O	664	668	were
O	669	677	assessed
O	677	678	.

B-outcome	679	681	At
I-outcome	682	685	the
I-outcome	686	689	8th
O	689	690	,
B-outcome	691	695	13th
O	695	696	,
O	697	700	and
B-outcome	701	705	16th
O	706	714	fraction
O	715	717	of
O	718	722	PMRT
O	722	723	,
B-outcome	724	729	grade
I-outcome	730	731	1
I-outcome	732	742	dermatitis
O	743	746	was
O	747	752	found
O	753	755	in
B-cv-bin-percent	756	758	42
O	758	759	,
B-cv-bin-percent	760	762	90
O	762	763	,
O	764	767	and
B-cv-bin-percent	768	770	90
I-cv-bin-percent	770	771	%
O	772	774	of
O	775	778	the
O	779	786	control
O	787	792	group
O	793	796	and
O	797	799	in
B-iv-bin-percent	800	802	16
O	802	803	,
B-iv-bin-percent	804	806	30
O	806	807	,
O	808	811	and
B-iv-bin-percent	812	814	71
I-iv-bin-percent	814	815	%
O	816	818	of
O	819	822	the
O	823	835	intervention
O	836	841	group
O	841	842	.

O	843	845	At
O	846	849	the
O	850	853	end
O	854	856	of
O	857	860	the
O	861	866	study
O	866	867	,
O	868	871	the
B-outcome	872	876	mean
I-outcome	877	884	Skindex
I-outcome	884	885	-
I-outcome	885	887	16
I-outcome	888	893	score
O	894	896	of
O	897	900	the
O	901	913	intervention
O	914	919	group
O	920	923	was
O	924	937	significantly
O	938	944	better
O	945	949	than
O	950	954	that
O	955	957	of
O	958	961	the
O	962	969	control
O	970	975	group
O	976	977	(
O	977	978	p
O	979	980	=
O	981	982	0
O	982	983	.
O	983	986	019
O	986	987	)
O	987	988	.

O	989	997	Addition
O	998	1000	of
O	1001	1003	an
O	1004	1012	emulsion
O	1013	1015	of
O	1016	1021	olive
O	1022	1025	oil
O	1026	1029	and
O	1030	1037	calcium
O	1038	1047	hydroxide
O	1048	1051	for
O	1052	1060	patients
O	1061	1071	undergoing
O	1072	1089	hypofractionation
O	1090	1094	PMRT
O	1095	1102	yielded
O	1103	1111	superior
O	1112	1122	preventive
O	1123	1130	results
O	1131	1135	over
O	1136	1137	a
O	1138	1145	general
O	1146	1150	skin
O	1151	1155	care
O	1156	1163	regimen
O	1164	1169	alone
O	1169	1170	,
O	1171	1173	in
O	1174	1179	terms
O	1180	1182	of
O	1183	1191	delaying
O	1192	1196	skin
O	1197	1205	toxicity
O	1205	1206	,
O	1207	1215	reducing
O	1216	1219	the
O	1220	1228	severity
O	1229	1231	of
O	1232	1237	acute
O	1238	1247	radiation
O	1248	1258	dermatitis
O	1258	1259	,
O	1260	1263	and
O	1264	1265	a
O	1266	1272	better
O	1273	1280	quality
O	1281	1283	of
O	1284	1288	life
O	1289	1291	in
O	1292	1295	the
O	1296	1308	intervention
O	1309	1314	group
O	1314	1315	.

O	1316	1323	However
O	1323	1324	,
O	1325	1326	a
O	1327	1333	larger
O	1334	1340	number
O	1341	1343	of
O	1344	1352	patients
O	1353	1357	will
O	1358	1360	be
O	1361	1369	required
O	1370	1372	to
O	1373	1380	confirm
O	1381	1385	this
O	1386	1392	result
O	1392	1393	.
